|
[1] PETESEN MC,SHULMAN GI. Mechanisms of insulin action and insulin resistance[J]. Physiol Rev,2018,98(4):2133-2223.
|
|
[2] SINGH VK,YADAV D. Diagnosis and management of chronic pancreatitis:A review[J]. JAMA,2019,322(24):2422-2434.
|
|
[3] KIRKEGARD J,CRONIN FD,HEIDE JU,et al. Acute pancreatitis and pancreatic cancer risk:A nationwide matched-cohort study in Denmark[J]. Gastroenterology,2018,154(6):1729-1736.
|
|
[4] KUMAR KV,MANRAI M,SOOD AK,et al. A clinical study of insulin resistance in patients with chronic pancreatitis[J]. Diabetes Metab Syndr,2017,11(Suppl 1):s283-s286.
|
|
[5] YANG J,WALDRON RT,SU HY,et al. Insulin promotes proliferation and fibrosing responses in activated pancreatic stellate cells[J]. Am J Physiol Gastrointest Liver Physiol,2016,311(4):g675-g687.
|
|
[6] TU J,YANG Y,ZHANG J,et al. Regulatory effect of chemerin and therapeutic efficacy of chemerin9 in pancreatogenic diabetes mellitus[J]. Mol Med Rep,2020,21(3):981-988.
|
|
[7] ZHOU N,YANG XZ. Metabonomics-based methods for metabolic disease:Research advances[J]. J Int Pharm Res,2015,42(5):561-567.(in Chinese)周宁，颜贤忠．代谢性疾病的代谢组学研究进展[J]．国际药学研究杂志，2015,42(5):561-567.
|
|
[8] TU J,ZHANG J,KE L,et al. Endocrine and exocrine pancreatic insufficiency after acute pancreatitis:Long-term followup study[J]. BMC Gastroenterol,2017,17(1):114-122.
|
|
[9] YUAN XL,ZHU XY,LI L. Research progress of the correlation of chronic pancreatitis and type 3c diabetes mellitus[J]. Chin Gen Pract,2017,20(25):3184-3186.(in Chinese)袁雪璐，祝祥云，李玲．慢性胰腺炎与3c型糖尿病相关性的研究进展[J]．中国全科医学，2017,20(25):3184-3186.
|
|
[10] HONZAWA N,FUJIMOTO K,KITAMURA T. Mechanisms of insulin action and insulin resistance[J]. Physiol Rev,2018,98(4):2133-2223.
|
|
[11] AKHTAR DH,IQBAL U,VAZQUEZ M,et al. Pathogenesis of insulin resistance and atherogenic dyslipidemia in non malcoholic fatty liver disease[J]. J Clin Transl Hepatol,2019,7(4):362-370.
|
|
[12] SLIWINSKA MM. Distribution of pancreatic polypeptide-secreting endocrine cells in nondiabetic and diabetic cases[J].Appl Immunohistochem Mol Morphol,2017,25(6):422-431.
|
|
[13] LIN YK,JOHNSTON PC,ARCE K,et al. Chronic pancreatitis and diabetes mellitus[J]. Curr Treat Options Gastroenterol,2015,13(3):319-331.
|
|
[14] HUANG CT,LIN CK,LEE TH,et al. Pancreatic fibrosis and chronic pancreatitis:Mini-review of non-histologic diagnosis for clinical applications[J]. Diagnostics(Basel),2020,10(2):87.
|
|
[15] LUO C,YANG H,TANG C,et al. Kaempferol alleviates insulin resistance via hepatic IKK/NF-kappaB slgnal inty Pe2 diabetic rats[J]. Int Immunopharmacol,2015,28(1):744-750.
|
|
[16] SOLINAS G,BECATTINI B. JNK at the crossroad of obesity,insulin resistance,and cell stress response[J]. Mol Metab,2016,6(2):174-184.
|
|
[17] LU L,YE X,YAO Q,et al. Egr2 enhances insulin resistance Via JAK2/STAT3/SOCS-1 Pathway in HepG2 cells treated with palmitate[J]. Gen Comp Endocrinol,2018,260:25-31.
|
|
[18] LU H,BOGDANOVIC E,YU Z,et al. Combined hy Perglycemia and hy Perinsullinemia-induced insulin resistance in adiPocytes is associated with dual signaling defects mediated by PKc-zeta[J]. Endocrinology,2018,159(4):1658-1677.
|
|
[19] ZANOTTO TM,QUARESMA P,GUADAGNINI D,et al. Blocking i NOS and endoPlasmic reticulum stress synergistically imProves insulin resistance in mice[J]. Mol Metab,2016,6(2):206-218.
|
|
[20] TANGVARASMICHAI S. Oxidative stress,insulin resistance,dyslipidemia and tr Pe 2 diabetes mellitus[J]. World J Diabetes,20l5,6(3):456-480.
|
|
[21] DAS P,BISWAS S,MUKHERJEE S,et al. Association of oxidative stress and obesity with insulin resistance in ty Pe 2 diabetes mellitus[J]. Mymensingh Med J,2016,25(1):148-152.
|
|
[22] GILLIES NA,PENDHARKAR SA,SINGH RG,et al. Lipid metabolism in patients with chronic hyperglycemia after an episode of acute pancreatitis[J]. Diabetes Metab Syndr,2016,11(s1):s233-s241.
|
|
[23] ALBAI O,ROMAN D. Hypertriglyceridemia,an important and independent risk factor for acute pancreatitis in patients with type 2 diabetes mellitus[J]. Ther Clin Risk Manag,2017,13:515-522.
|
|
[24] DASGUPTA R,NAIK D,THOMAS N. Emerging concepts in the pathogenesis of diabetes in fibrocalculous pancreatic diabetes[J]. J Diabetes,2015,7(6):754-761.
|
|
[25] JAGANATHAN R,RAVINDRAN R,DANASEKARAN S. Emerging role of Adipocytokines in type 2 diabetes as mediators of insulin resistance and Cardiovascular disease[J]. Can J Diabetes,2018,42(4):446-456.
|
|
[26] ASGHAR A,SHELKH N. Role of innune cells in obesity induced low grade inflammation and insulin resistance[J]. Cell Immunol,2017,315:18-26
|
|
[27] OSEGBE I,OKPARA H,AZINGE E. Relationship between serum leptin and insulin resistance among obese Nigerian women[J]. Ann Afr Med,2016,l5(1):14-19.
|
|
[28] WEI YQ,LI M,YU J. Research progress in the relationship between chronic inflammation and insulin resistance[J]. Clin Pathol Res,2019,39(3):640-645.(in Chinese)魏伊秋，李满，余佳．慢性炎症与胰岛素抵抗机制关系的研究进展[J]．临床与病例杂志，2019,39(3):640-645.
|
|
[29] FANG ZW,DING HX. Effect of intensive hypoglycemic regimens on blood glucose variability in patients with severe pancreatitis[J]. Chin J Pancreatol,2016,16(6):404-406.(in Chinese)范志伟，丁惠霞．强化降糖方案对重症急性胰腺炎患者血糖变异性的影响[J]．中华胰腺病杂志，2016,16(6):404-406.
|
|
[30] de-FREITAS-JUNIOR JCM,ANDRADE-DA-COSTA J,SILVA MC,et al. Glycans as regulatory elements of the insulin/IGF system:Impact in cancer progression[J]. Int J Mol Sci,2017,18(9):1921.
|
|
[31] SINGH S,EARLE CC,BAE SJ,et al. Incidence of diabetes in color-ectal cancer survivors[J]. J Natl Cancer Inst,2016,108(6):djv402.
|
|
[32] OZER K,HORSANALI MO,GORGEL SN,et al. Diabetes is an important risk factor for metastasis in non-muscle-invasive bladder cancer[J]. Asian Pac J Cancer Prev,2016,17(1):105-108
|
|
[33] DA BM,GRONDECKA A. Diabetes as a risk factor of hospitalization in the surgical ward due to cancer in the elderly and middle-aged population[J]. Arch Med Sci,2017,13(5):1025-1030.
|
|
[34] AMUTHA P,RAJKUMAR T. Role of insulin-like growth factor,insulin-like growth factor receptors,and insulin-like growth factor-binding proteins in ovarian cancer[J]. Indian J Med Paediatr Oncol,2017,38(2):198-206.
|
|
[35] DELL AE,FULGENZI CAM,MINELLI A,et al. Prognostic and predictive factors in Pancreatic cancer[J]. Oncotarget,2020,11(10):924-941.
|
|
[36] REN HT,LI RP,WANG YJ. Complications after pancreaticoduodenectomy in pancreatic cancer patients with diabetes mellitus[J]. Pract Clin Med,2016,17(5):27-29.(in Chinese)任浩棠，李瑞平，王毅钧．胰腺癌并糖尿病患者行胰十二指肠切除术后并发症的研究[J]．实用临床医学杂志，2016,17(5):27-29.
|
DownLoad: